Novel targets for slowing CKD progression

被引：7

作者：

Carrero, Juan Jesus ^{[1
]}

Stenvinkel, Peter ^{[1
]}

机构：

[1] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Renal Med, Dept Clin Sci Intervent & Technol, SE-14186 Stockholm, Sweden

来源：

NATURE REVIEWS NEPHROLOGY | 2011年 / 7卷 / 02期

关键词：

CHRONIC KIDNEY-DISEASE; LONG-TERM OUTCOMES; BICARBONATE; RISK;

D O I：

10.1038/nrneph.2010.177

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

several 2010 trials have provided novel information on how best to manage patients with predialysis chronic kidney disease (ckd). armed with these new findings, nephrologists can find new means of slowing ckd progression by targeting blood-pressure control, acidosis and serum uric acid levels.

引用

页码：65 / 66

页数：2

共 50 条

[31] Insignificant impact of VUR on the progression of CKD in children with CAKUT
Ishikura, Kenji
Uemura, Osamu
Hamasaki, Yuko
Nakai, Hideo
Ito, Shuichi
Harada, Ryoko
Hattori, Motoshi
Ohashi, Yasuo
Tanaka, Ryojiro
Nakanishi, Koichi
Kaneko, Tetsuji
Iijima, Kazumoto
Honda, Masataka
PEDIATRIC NEPHROLOGY, 2016, 31 (01) : 105 - 112
[32] Kidney failure, CKD progression and mortality after nephrectomy
Ellis, Robert J.
Cameron, Anne
Gobe, Glenda C.
Diwan, Vishal
Healy, Helen G.
Lee, Jeremy
Tan, Ken-Soon
Venuthurupalli, Sree
Zhang, Jianzhen
Hoy, Wendy E.
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (09) : 2239 - 2245
[33] Predicting Duration of CKD Progression in Patients with Hypertension and Diabetes
Khannara, Warangkana
Iam-On, Natthakan
Boongoen, Tossapon
INTELLIGENT AND EVOLUTIONARY SYSTEMS, IES 2015, 2016, 5 : 129 - 141
[34] Cognitive Impairment and Progression of CKD
Tamura, Manjula Kurella
Yaffe, Kristine
Hsu, Chi-yuan
Yang, Jingrong
Sozio, Stephen
Fischer, Michael
Chen, Jing
Ojo, Akinlolu
DeLuca, Jennifer
Xie, Dawei
Vittinghoff, Eric
Go, Alan S.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 68 (01) : 77 - 83
[35] Monoclonal Gammopathies and CKD Progression
Chowdhury, Raad
Gupta, Shruti
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (03): : 280 - 282
[36] Metabolic Acidosis and CKD Progression
Madias, Nicolaos E.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (02): : 310 - 312
[37] Self-reported Medication Adherence and CKD Progression
Cedillo-Couvert, Esteban A.
Ricardo, Ana C.
Chen, Jinsong
Cohan, Janet
Fischer, Michael J.
Krousel-Wood, Marie
Kusek, John W.
Lederer, Swati
Lustigova, Eva
Ojo, Akinlolu
Porter, Anna C.
Sharp, Lisa K.
Sondheimer, James
Diamantidis, Clarissa
Wang, Xue
Roy, Jason
Lash, James P.
KIDNEY INTERNATIONAL REPORTS, 2018, 3 (03): : 645 - 651
[38] Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides
Schanstra, Joost P.
Zuerbig, Petra
Alkhalaf, Alaa
Argiles, Angel
Bakker, Stephan J. L.
Beige, Joachim
Bilo, Henk J. G.
Chatzikyrkou, Christos
Dakna, Mohammed
Dawson, Jesse
Delles, Christian
Haller, Hermann
Haubitz, Marion
Husi, Holger
Jankowski, Joachim
Jerums, George
Kleefstra, Nanne
Kuznetsova, Tatiana
Maahs, David M.
Menne, Jan
Mullen, William
Ortiz, Alberto
Persson, Frederik
Rossing, Peter
Ruggenenti, Piero
Rychlik, Ivan
Serra, Andreas L.
Siwy, Justyna
Snell-Bergeon, Janet
Spasovski, Goce
Staessen, Jan A.
Vlahou, Antonia
Mischak, Harald
Vanholder, Raymond
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (08): : 1999 - 2010
[39] Statin Use and the Progression of Coronary Artery Calcification in CKD: Findings From the KNOW-CKD Study
Yang, Jihyun
Lee, Kyu-Beck
Kim, Hyang
Kim, Soo Wan
Kim, Yeong Hoon
Sung, Su Ah
Kim, Jayoun
Oh, Kook-Hwan
Jung, Ji Yong
Hyun, Young Youl
KIDNEY INTERNATIONAL REPORTS, 2024, 9 (10): : 3027 - 3034
[40] CKD-MBD: from the Pathogenesis to the Identification and Development of Potential Novel Therapeutic Targets
Elias, Rosilene Motta
Dalboni, Maria Aparecida
Coelho, Ana Carolina E.
Moyses, Rosa M. A.
CURRENT OSTEOPOROSIS REPORTS, 2018, 16 (06) : 693 - 702

← 1 2 3 4 5 →